Prolapse; Female
15
3
6
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
REDUCE Trial- Reducing Prolapse Recurrence
Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery
Posterior Mesh Fixation at the Levator Ani Level in Apical Pelvic Organ Prolapse
Barbed-suture Efficiency Study for Sacrocolpopexy
Pragmatic Evaluation of Performance and Safety of the Anchorsure® Transvaginal Device for Surgical Treatment of Apical Prolapse in Women
Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology
STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial
Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment
Impact of Preop Video on Patient Anxiety
Concomitant Posterior Colporrhaphy on Bowel Functions in Pelvic Organ Prolapse Repair
Evaluation of the Safety, Performance, and Tolerability of the Sacromesh® Medical Device in the Treatment of Prolapse by Promontofixation in a Population of Patients Followed Over the Long Term.
Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy
Effects of the Hypopressive Exercises in Women With Pelvic Organ Prolapse
What Affects Willingness to Self-manage a Pessary?
Cost-effectiveness Comparison Between Vaginal Versus Robotic Mesh Surgery for Apical Prolapse: Prospective, Cohort Study